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1. Purpose 
Protein fusions are currently not supported by most assembly standards. This assembly 
standard aims to provide the basis of a solution to a biobrick-friendly protein fusion 
mechanism that supports the current favorite assembly standard 10 (RFC10) and hence 
allows utilization of most of the current biobricks database. 
 
2. Relation to other BBF RFCs 
BBF RFC10 & BBF RFC15.  This RFC does not replace the aforementioned standards. It 
simply describes practices on how to achieve protein fusions that are consistent with 
RFC10 and draws inspiration and updates on the notion of RFC15. 
 
3. Copyright Notice 
Copyright (C) The BioBricks Foundation (2009). All Rights Reserved. 
 
4.1 Introduction 
 
4.1.1 RFC10 and the protein fusion problem 
There are various assembly standards that can be used to assemble biobrick parts together 
but the current favourite and most promoted is “Assembly Standard 10” (RFC10). In 
assembly standard 10 each biobrick is surrounded immediately upstream and downstream 
by strings of DNA known as a prefix (upstream) and suffix (downstream) each carrying 
DNA sequences recognised by two separate restriction enzymes, known as restriction 
sites. The prefix has an EcoRI and an XbaI restriction site, whilst the suffix has a SpeI 
and PstI site. This allows the easy removal of a part and its subsequent placement next to 
another part, either upstream or downstream, as one prefix restriction site (XbaI) creates 
compatible ends with a suffix restriction site (SpeI), after the DNA has been cleaved by 
the respective enzymes [1,2]. 
 
RFC10 regulations do not support protein fusions. Under RFC10 regulations when two 
protein encoding biobricks are joined, i.e. when the XbaI site ligates with SpeI the 
resulting sequence, known as DNA scar, is 5- TACTAG-3. This poses a problem as TAG 
encodes for a stop codon. The problem however is not just that the DNA scar encodes for 
a stop codon but in addition each protein coding biobrick has to have two consecutive 
stop codons 5-TAA TAA-3 at the C-terminal tail [1,2]. 
 
4.1.2 Other Assembly Standards 
No current assembly standard satisfactorily addresses the problem of protein fusion. 
Assembly standard 23 removes a base pair from the prefix and suffix respectively giving 
a 5-ACT AGA-3 scar, which replaces the DNA scar stop codon but instead inserts a 
problematic Arginine residue that is highly positively charged and also not preferred by 
the E.coli translational machinery. Assembly standard 25 adds an extra restriction 
consensus prior to the start codon of the upstream protein and this would upset the 5-6 
base pair spacer rule that should exist between the RBS and the protein to ensure that 
translation is optimal [1]. As most biobricks in the database currently have two TAA stop 
codons at their 3’ end, the problem remains even when the DNA scar is manipulated as it 
is the nature of protein encoding biobricks to carry stop codons. 
 
A viable solution is offered partly by assembly standard 15 (RFC 15) [3], a concept 
known as a Bioscaffold. A bioscaffold is a biobrick that is placed between two protein 
coding biobricks. The bioscaffold carries consensus sequences recognised by atypical 
Type II enzymes that cleave DNA outside their recognition consensus with various 
mechanisms. This enables the reach beyond the consensus and the possibility of cleaving 
away the stop codon sequences of the protein coding biobricks. Although some notion of 
Bioscaffolds is provided by iGEM, the current scaffolds are not compatible as biobricks 
or not available in biobrick format and each assembly has to be carefully considered on a 
case by case basis, which is in conflict with the iGEM ethos of standardisation. What is 
required is an RFC10 upwards compatible Bioscaffold that is so versatile that can be used 
with almost all biobricks without extra considerations. 
 
4.2 The Bioscaffold­Linker overview 
As figure 1 illustrates, the Bioscaffold-Linker shows a number of features. On the left and 
right hand sides two unique restriction sites are found. These sequences are recognised by 
non-conventional Type-IIS enzymes that digest DNA outside of these recognition 
sequences. On application they collapse the Bioscaffold and at the same time convert the 
upstream protein coding part stop codons into a single amino acid and maintain the 
Methionine start codon of the downstream protein coding part. It also adds a flexible 
Glycine-Serine-Glycine linker between the two protein coding regions, allowing each 
individual component to fold correctly and independently following translation. In 
addition a translational buffer exists within the Bioscaffold. A protein translational buffer 
is a series of stop codons found in different frames such that if the application of the 
Bioscaffold fails then the downstream protein coding region will not be expressed. It is 
important to note that everything is kept in frame in the DNA sequence after the 
application of the Bioscaffold. 
 
 
Figure 1: The structure of the Bioscaffold-Linker illustrating its features. The arrowhead pointing to 
the right indicates forward orientation and the left arrow head reverse orientation. 
4.3 The Bioscaffold­Linker Specific Enzymes. 
The Bioscaffold specific enzymes BpuEI and BseRI were chosen with a number of 
considerations in mind. BpuEI has an asymmetric six base pair recognition sequence, 
CTTGAG. Following from basic probability theory this means that the sequence occurs 
at random in approximately every 46/2 base pairs (2048 base pairs; once every 4096bases 
on each strand of DNA). However the site frequency in the E.coli genome is even less 
than half the expected [4]. BseRI has a symmetric 6 base pair recognition sequence, 
GAGGAG, which means that the site appears every 46 at random (4096 base pairs) but 
the site frequency in the E.coli genome is about 1/4 of that expected [5]. Thus such 
sequences appear scarcely in the genome and can be used with most of the genes in the 
Biobrick database. Also neither sequence appears on the backbone plasmid pSB2K3 and 
hence this plasmid may be chosen as the preferred backbone for protein fusions using the 
Bioscaffold Linker. Many more enzymes have similar properties but are more expensive 
to buy and sometimes not commercially available. 
 
Another consideration is that atypical Type II enzymes are very sensitive to buffer 
conditions and to the context that their recognition site is found. Such enzymes include 
CspCI (Type IIB) to which a Bioscaffold-Linker has also been developed but could not 
be tested as no assembly standard 10 compatible plasmid backbone is yet available (see 
application section later). A potential advantage of CspCI is that it has an asymmetric 7bp 
recognition sequence, hence it appears at random every 47/2 bp (8192bp). A potential 
disadvantage is that CspCI has 1 base pair discrepancy in restricting DNA, base on the 
context of the recognition sequence, but the CspCI bioscaffold has been designed taking 
into consideration this. All three chosen enzymes have been recognised as “time-saver 
qualified” by NEB and one unit can digest 1µg of DNA in 5min, saving time in the 
Bioscaffold application. 
 
4.4 Bioscaffold­Linker Application 
 
4.4.1 Required parts 
The following parts MUST be used when applying the Bioscaffold-Linker: 
 
1. Plasmid Backbone: pSB2K3 (hereafter called the plasmid backbone). 
2. Bioscaffold-Linker: BBa_K259002 (hereafter called the Bioscaffold). 
3. Upstream Protein: The protein encoding gene MUST be compatible with RFC10. 
4. Downstream Protein: The protein encoding gene MUST be compatible with 
RFC10. 
5. Bioscaffold Specific Enzymes: Currently BpuEI and BseRI. Supplied from NEB 
and used under NEB guidelines. Avoid incubation times greater than one hour 
(recommended times 5-50 min). 
 
The usage of pSB2K3 is essential as it has no Bioscaffold conflicting sequences with 
respect to the restriction enzymes used. Also the downstream/upstream protein encoding 
genes MUST NOT carry the recognition consensus of the Bioscaffold specific enzymes. 
 
Also standard assembly refers to the assembly created with RFC10 rules. 
4.4.2 Bioscaffold­Linker Application 
The application of the Bioscaffold is straightforward. Firstly a standard assembly is 
created on a pSB2K3 plasmid backbone with the Bioscaffold in the middle of two protein 
coding parts as shown in figure 2. Then Bioscaffold specific enzymes are used to collapse 
the Bioscaffold, creating scarless fusions.  
 
 
Figure 2: The first step in applying the Bioscaffold is to create an assembly standard 10 where the 
bioscaffold is placed between two protein encoding genes. The destination plasmid must be pSB2K3. 
 
The left hand side features a Type-IIS enzyme recognition sequence, BpuEI,  that will 
cleave a DNA sequence a few base pairs after the recognition site. Two such sites have 
been incorporated in inverse orientation, allowing cleavage that removes the stop codons 
from the upstream part and a small sequence from the Bioscaffold. Complementary 
overhangs are created between the partly cleaved stop codon and the Bioscaffold 
sequence, which when ligated convert the stop codon to a Tyrosine aminoacid. The first 
step in applying the Bioscaffold after it has been incorporated between two protein 
encoding genes is to restrict with BpuEI and ligate the restricted product.  
 
On the right hand site there exist a different Type IIS enzyme recognition sequence, 
BseRI, again in two copies with inverse orientation. BseRI cleaves both upstream and 
downstream from the sequence and in doing so collapses the Bioscaffold and creates 
complementary DNA sequence ends between the Bioscaffold and the downstream coding 
gene that upon ligation will give a Methionine start codon (see figure 3). As the Met start 
codon is maintained this leads to a scarless downstream fusion. Hence for correct usage 
of the scaffold after the first round of restrictrion and ligation with BpuEI and ligase 
enzyme is to incubate the product with BseRI, and ligate the complementary ends. 
 
In the middle of the Bioscaffold sequence there exists a region encoding a Gly-Ser-Gly 
linker bridge. This is maintained if the application of the Bioscaffold is done in the 
correct order as outlined in the two paragraphs above.  
 
In case the Bioscaffold has failed to perform as expected the translational buffer (for 
explanation see section 4.2) will prevent the translational machinery of the cell 
translating the region encoding the downstream protein. 
 
 
Figure 3: The manipulation of the Bioscaffold in order to create a protein fusion. The sequences in 
red are protein encoding genes. The sequences in orange are the Bioscaffold specific restriction sites 
and the sequences in blue are aminoacids within the bioscaffold involved in restriction/ligation. The 
arrows indicate the reach of the restriction enzymes in each step. In Step 1 part (a) we illustrate the 
reach of BpuEI and in (b) the subsequent product after ligation giving a TAC codon. In Step 2 part 
(a) we illustrate the reach of BseRI restriction enzyme and in (b) the product after ligation giving an 
ATG codon. 
 
 
 
4.4.3 Recommended Assembly 
Although 3-way ligation is promoted by the iGEM organisation we recommend that 
when creating an assembly of the kind 5’-Upstream Protein-Bioscaffold-Downstream 
Protein-3’ you use a 2-way ligation and take advantage of the fact that the Bioscaffold is 
already found on a pSB2K3 backbone plasmid. As a first step to insert a biobrick 
upstream of the bioscaffold digest both parts with EcoRI and XbaI and then proceed with 
a ligation reaction. Secondly, to insert a biobrick part downstream of the Bioscaffold 
digest both parts with SpeI and PstI and then proceed with a ligation reaction. This 
sequence of events maximises the correct ligation products to be obtained with respect to 
a more complex 3-way ligation reaction that will need to be carried out twice (once to 
obtain 5’-Upstream Protein-Bioscaffold-3’, and once to obtain 5’-Upstream Protein-
Bioscaffold-Downstream Protein-3’). Do make sure that after each restriction and 
ligation enzyme denaturation and DNA clean-up is performed to remove any enzymes 
that might impede on subsequent steps. 
 
4.5 Associated Biobricks developed for Bioscaffold­Linker 
The following biobricks have been designed and developed to be used as Bioscaffold-
Linkers for protein fusions: 
 
• K259002 - BpuEI BseRI Bioscaffold 
• K259004 - BpuEI  CspCI Standard Bioscaffold 
• K259009 - BpuEI CspCI Version 2 Bioscaffold 
• K259010- BpuEI CspCI Version 3 Bioscaffold 
 
4.6 Requests for future updates on plasmid backbones 
The authors kindly request the iGEM team to consider mutating the single CspCI site 
within the pSB2K3 plasmid backbone. As CspCI has a 7bp asymmetric recognition 
sequence this means that it can provide a very good alternative bioscaffold recognition 
sequence in cases where conflicts with the protein encoding genes occur. 
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